RCL
59
-2
UA
39
4
TGNA
37
-10
LYB
58
5
RHI
39
2
VFC
38
4
ORCL
58
2
WU
42
2
DO
48
4
ADT
61
-2
XYL
30
-2
TDC
50
-2
EOG
55
3
KMB
36
-4
RL
43
3
URI
73
5
AIZ
66
2
CNP
44
-13
CVX
44
3
WFC
41
-9
RCL
59
-2
UA
39
4
TGNA
37
-10
LYB
58
5
RHI
39
2
VFC
38
4
ORCL
58
2
WU
42
2
DO
48
4
ADT
61
-2
XYL
30
-2
TDC
50
-2
EOG
55
3
KMB
36
-4
RL
43
3
URI
73
5
AIZ
66
2
CNP
44
-13
CVX
44
3
WFC
41
-9
Financhill
Back

Royalty Pharma PLC Stock Predictions

Prepare now for a ChatGPT IPO announcement

Click here to see more
Sell
50

RPRX
Royalty Pharma PLC

Last Price:
30.28
Seasonality Move:
1.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Take advantage of the biggest IPO in history

Click here to see more

Royalty Pharma PLC Stock Forecast

  • Over the next 52 weeks, Royalty Pharma PLC has on average historically fallen by 8.9% based on the past 3 years of stock performance.
  • Royalty Pharma PLC has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Royalty Pharma PLC Stock Undervalued?
    The current Royalty Pharma PLC [RPRX] share price is $30.27. The Score for RPRX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • RPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Royalty Pharma PLC Stock Go Up Next Year?

  • Over the next 52 weeks, Royalty Pharma PLC has on average historically fallen by 8.9% based on the past 3 years of stock performance.

Royalty Pharma PLC Stock Rating

Sell
50
Royalty Pharma PLC (RPRX) is a Sell

Is Royalty Pharma PLC overpriced?

  • Royalty Pharma PLC has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Royalty Pharma PLC Stock Price History

Is RPRX stock going to rise?

  • The current trend is relatively stagnant and RPRX is experiencing slight selling pressure.

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
royaltypharma.com

52-Week Data

52-Week High:
44.47
52-Week Low:
28.98

Prediction Charts

Market Cap:
13.59B
Price in USD:
30.27
Volume:
1.71M
Beta:
0.39

Technical Analysis

SMA50:
30.46
SMA100:
32.24
SMA200:
35.36
52-Wk Change:
-27.88%

Stock Predictions

  • Is Royalty Pharma PLC stock public?
    Yes, Royalty Pharma PLC is a publicly traded company.
  • What is the Royalty Pharma PLC stock quote today?
    The Royalty Pharma PLC stock price is 30.27 USD today.
  • How to buy Royalty Pharma PLC stock online?
    You can buy Royalty Pharma PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-15 29.97 29.80 30.22 29.73
Aug-16 29.59 29.69 29.72 29.26
Aug-17 29.62 29.27 29.83 29.24
Aug-18 29.18 29.34 29.51 28.98
Aug-21 29.30 29.64 30.39 29.19
Aug-22 29.60 29.62 29.80 29.48
Aug-23 29.71 29.68 29.75 29.50
Aug-24 29.68 29.56 29.90 29.43
Aug-25 29.55 30.21 30.26 29.38
Aug-28 30.23 30.39 30.68 30.19
Aug-29 30.45 30.73 30.86 30.10
Aug-30 30.81 30.37 30.87 30.31
Aug-31 30.39 29.81 30.42 29.77
Sep-1 30.00 30.27 30.67 30.00

Royalty Pharma PLC Earnings

Royalty Pharma PLC Earnings Report: Per Share Royalty Pharma PLC Earnings Q1 Q2 Q3 and Q4 last year and next year.

Royalty Pharma PLC Forecast Revenue Growth

Royalty Pharma PLC Stock Analysis: Historical quarterly revenues per share for Royalty Pharma PLC and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.19 per share, an increase this year of $0.50 per share, and a decrease next year of $0.23 per share.

* Royalty Pharma PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.